Provided herein are compounds identified as inhibitors of ADAR1 activity, such as compounds having the formula: (I) or (II), or a pharmaceutically acceptable salt or tautomer thereof, that are useful in treating cancer and other disorders, include those related to abnormal ADAR1 expression.
Provided herein are compounds identified as inhibitors of ADAR1 activity, such as compounds having the formula: (I) or (II), or a pharmaceutically acceptable salt or tautomer thereof, that are useful in treating cancer and other disorders, include those related to abnormal ADAR1 expression.